SOX2 and demyelinating disease of central nervous system: Considering the potential regenerative properties of Schwann cells, the targeting of p75NTR/Sox2-expressing cells and the development of strategies designed to enhance their differentiation into competent remyelinating cells appears to be a promising therapeutic approach to achieve regeneration in inflammatory/demyelinating CNS diseases.